Eli Lilly loses case against Florida compounding pharmacy

Eli Lil­ly suf­fered an­oth­er loss this week in its le­gal cam­paign against com­pound­ed ver­sions of its pop­u­lar di­a­betes and weight loss drug tirzepatide.

A Flori­da fed­er­al judge tossed Lil­ly’s law­suit against a Mi­a­mi com­pound­ing phar­ma­cy on Wednes­day, rul­ing that Lil­ly can’t “use state law as a back door to pri­vate­ly en­force” the Fed­er­al Food, Drug, and Cos­met­ic Act (FD­CA). The de­ci­sion comes just a cou­ple months af­ter an­oth­er Flori­da judge dis­missed a sep­a­rate case Lil­ly brought against a dif­fer­ent com­pound­ing phar­ma­cy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.